Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to -$966000.0.

  • Celularity's Other Working Capital Changes fell 18313.25% to -$966000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year increase of 3534.51%. This contributed to the annual value of -$905000.0 for FY2024, which is 8385.66% up from last year.
  • Per Celularity's latest filing, its Other Working Capital Changes stood at -$966000.0 for Q3 2025, which was down 18313.25% from $420000.0 recorded in Q2 2025.
  • Celularity's Other Working Capital Changes' 5-year high stood at $1.9 million during Q3 2022, with a 5-year trough of -$5.6 million in Q3 2021.
  • For the 5-year period, Celularity's Other Working Capital Changes averaged around -$803421.1, with its median value being -$556000.0 (2024).
  • Over the last 5 years, Celularity's Other Working Capital Changes had its largest YoY gain of 280708.51% in 2021, and its largest YoY loss of 1836903.34% in 2021.
  • Quarter analysis of 5 years shows Celularity's Other Working Capital Changes stood at $251000.0 in 2021, then plummeted by 501.2% to -$1.0 million in 2022, then plummeted by 240.32% to -$3.4 million in 2023, then skyrocketed by 64.49% to -$1.2 million in 2024, then grew by 20.62% to -$966000.0 in 2025.
  • Its Other Working Capital Changes was -$966000.0 in Q3 2025, compared to $420000.0 in Q2 2025 and -$251000.0 in Q1 2025.